Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Advances in Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/bs.acr.2014.10.002PMID 25640266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood–Brain and Blood–Spinal Cord Barriers

  2014cited by this paper
• Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease

  2014cited by this paper
• Emerging Roles of Pericytes in the Regulation of the Neurovascular Unit in Health and Disease

  2014cited by this paper
• A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources

  2014cited by this paper
• Sphingolipid Signaling Reduces Basal P-Glycoprotein Activity in Renal Proximal Tubule

  2014cited by this paper
• 1α,25-Dihydroxyvitamin D3 Reduces Cerebral Amyloid-β Accumulation and Improves Cognition in Mouse Models of Alzheimer's Disease

  2014cited by this paper
• The Cross-Talk between Canonical and Non-Canonical Wnt-Dependent Pathways Regulates P-Glycoprotein Expression in Human Blood–Brain Barrier Cells

  2014cited by this paper
• St. John's Wort Reduces Beta‐Amyloid Accumulation in a Double Transgenic Alzheimer's Disease Mouse Model—Role of P‐Glycoprotein

  2014cited by this paper
• FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P‐glycoprotein and multidrug resistance protein 1

  2014cited by this paper
• Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease.

  2014cited by this paper
• Signaling pathways that regulate basal ABC transporter activity at the blood- brain barrier.

  2014cited by this paper
• Estrogen biology: new insights into GPER function and clinical opportunities.

  2014cited by this paper
• Mrp1 is Essential for Sphingolipid Signaling to P-Glycoprotein in Mouse Blood–Brain and Blood–Spinal Cord Barriers

  2013cited by this paper
• Blood–brain barrier structure and function and the challenges for CNS drug delivery

  2013cited by this paper
• Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection.

  2013cited by this paper
• Role of nuclear receptors in the regulation of drug transporters in the brain.

  2013cited by this paper
• Quantitative fluorescence microscopy provides high resolution imaging of passive diffusion and P-gp mediated efflux at the in vivo blood-brain barrier.

  2013cited by this paper
• The ATM protein kinase: regulating the cellular response to genotoxic stress, and more

  2013cited by this paper
• Why Clinical Modulation of Efflux Transport at the Human Blood–Brain Barrier Is Unlikely: The ITC Evidence‐Based Position

  2013cited by this paper
• In vivo induction of P‐glycoprotein expression at the mouse blood–brain barrier: an intracerebral microdialysis study

  2013cited by this paper
• The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?

  2012cited by this paper
• Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells

  2012cited by this paper
• Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain

  2012cited by this paper
• Physiology and Pathophysiology of the Blood-Brain Barrier

  2012cited by this paper
• Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.

  2012cited by this paper
• Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.

  2012cited by this paper
• P‐glycoprotein trafficking at the blood–brain barrier altered by peripheral inflammatory hyperalgesia

  2012cited by this paper
• Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of action.

  2012cited by this paper
• Liver X Receptor Activation Enhances Blood–Brain Barrier Integrity in the Ischemic Brain and Increases the Abundance of ATP‐Binding Cassette Transporters ABCB1 and ABCC1 on Brain Capillary Cells

  2012cited by this paper
• Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.

  2012cited by this paper
• ABC Transporter Function and Regulation at the Blood–Spinal Cord Barrier

  2012cited by this paper
• P‐glycoprotein imaging in temporal lobe epilepsy: In vivo PET experiments with the Pgp substrate [11C]‐verapamil

  2012cited by this paper
• Overview and introduction: The blood–brain barrier in health and disease

  2012cited by this paper
• 1α,25‐Dihydroxyvitamin D3‐liganded vitamin D receptor increases expression and transport activity of P‐glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells

  2012cited by this paper
• Role of CAR and PXR in xenobiotic sensing and metabolism

  2012cited by this paper
• Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.

  2011cited by this paper
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011cited by this paper
• Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.

  2011cited by this paper
• Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.

  2011cited by this paper
• ABC transporters in the CNS - an inventory.

  2011cited by this paper
• Aryl hydrocarbon receptor‐mediated up‐regulation of ATP‐driven xenobiotic efflux transporters at the blood‐brain barrier

  2011cited by this paper
• MDR1–P‐glycoprotein (ABCB1)‐Mediated Disposition of Amyloid‐β Peptides: Implications for the Pathogenesis and Therapy of Alzheimer's Disease

  2010cited by this paper
• Rapid, Reversible Modulation of Blood–Brain BarrierP-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor

  2010cited by this paper
• Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

  2010cited by this paper
• Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier

  2010cited by this paper
• The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity.

  2010cited by this paper
• BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol.

  2010cited by this paper
• Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.

  2010cited by this paper
• Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver.

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Intact Lipid Rafts Regulate HIV-1 Tat Protein-Induced Activation of the Rho Signaling and Upregulation of P-Glycoprotein in Brain Endothelial Cells

  2010cited by this paper
• 17-β-Estradiol: A Powerful Modulator of Blood–Brain Barrier BCRP Activity

  2010cited by this paper
• Activation of PKC Isoform βI at the Blood–Brain Barrier Rapidly Decreases P-Glycoprotein Activity and Enhances Drug Delivery to the Brain

  2010cited by this paper
• Rapid Loss of Blood–Brain Barrier P-Glycoprotein Activity through Transporter Internalization Demonstrated Using a Novel in Situ Proteolysis Protection Assay

  2010cited by this paper
• Estrogen Receptor β Signaling through Phosphatase and Tensin Homolog/Phosphoinositide 3-Kinase/Akt/Glycogen Synthase Kinase 3 Down-Regulates Blood-Brain Barrier Breast Cancer Resistance Protein

  2010cited by this paper
• Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition.

  2009cited by this paper
• Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.

  2008cited by this paper
• Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P‐glycoprotein up‐regulation at the blood‐brain barrier

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Seizure-Induced Up-Regulation of P-Glycoprotein at the Blood-Brain Barrier through Glutamate and Cyclooxygenase-2 Signaling

  2008cited by this paper
• Coordinated Nuclear Receptor Regulation of the Efflux Transporter, Mrp2, and the Phase-Ii Metabolizing Enzyme, GSTπ, at the Blood—Brain Barrier

  2008cited by this paper
• Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction.

  2008cited by this paper
• Localization of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) in Lipid Rafts/Caveolae and Modulation of Its Activity by Cholesterol in Vitro

  2007cited by this paper
• Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier.

  2007cited by this paper
• ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory Epilepsy

  2007cited by this paper
• Tumor Necrosis Factor α and Endothelin-1 Increase P-Glycoprotein Expression and Transport Activity at the Blood-Brain Barrier

  2007cited by this paper
• Role of drug efflux carriers in the healthy and diseased brain

  2006cited by this paper
• In Vivo Activation of Human Pregnane X Receptor Tightens the Blood-Brain Barrier to Methadone through P-Glycoprotein Up-Regulation

  2006cited by this paper
• Modulation of p‐glycoprotein function by caveolin‐1 phosphorylation

  2006cited by this paper
• Rapid Modulation of P-Glycoprotein-Mediated Transport at the Blood-Brain Barrier by Tumor Necrosis Factor-α and Lipopolysaccharide

  2006cited by this paper
• P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.

  2005cited by this paper
• Lidocaine: a foot in the door of the inner vestibule prevents ultra-slow inactivation of a voltage-gated sodium channel.

  2004cited by this paper
• Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier.

  2004cited by this paper
• Rapid Regulation of P-Glycoprotein at the Blood-Brain Barrier by Endothelin-1

  2004cited by this paper
• Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.

  2002cited by this paper
• Functional expression and localization of P‐glycoprotein at the blood brain barrier

  2002cited by this paper
• Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

  2000cited by this paper

• Explaining blood-brain barrier permeability by synergistic effect on molecular substructures

  2025cites this paper
• Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer

  2025cites this paper
• Understanding the Blood-Brain Barrier: From Physiology to Pathology.

  2025cites this paper
• Protective effects of dietary supplementation of Bacillus Subtilis MZ18 against the reproductive toxicity of zearalenone in pregnant rats.

  2025cites this paper
• Methotrexate resistance and its regulatory mechanisms in pediatric tumors and beyond.

  2025cites this paper
• Regulation of Intestinal Butyrate Transporters by Oxidative and Inflammatory Status

  2025cites this paper
• Plasma protein signatures associated with functional outcome heterogeneity in rtPA-treated acute ischemic stroke.

  2025cites this paper
• Progresses in the establishment, evaluation, and application of in vitro blood–brain barrier models

  2024cites this paper
• Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System

  2024cites this paper
• Electroacupuncture stimulation enhances the permeability of the blood-brain barrier: A systematic review and meta-analysis of preclinical evidence and possible mechanisms

  2024cites this paper
• Treating Alzheimer's Disease Using Nanoparticle-Mediated Drug Delivery Strategies/Systems.

  2024cites this paper
• P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators.

  2024cites this paper
• Unveiling the Mysteries of the Blood-Brain Barrier: The Problem of the Brain/spinal Pharmacotherapy.

  2024cites this paper
• Systematic Druggable Genome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome After Ischemic Stroke

  2024cites this paper
• Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies

  2024cites this paper
• Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases

  2024cites this paper
• Non-genomic ERα-AMPK signaling regulates sex-dependent Bcrp transport activity at the blood-brain barrier.

  2024cites this paper
• Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients

  2023cites this paper
• Structure of the Blood Brain Barrier and its role in the transporters for the movement of substrates across the barriers.

  2023cites this paper
• The Alternating Access Mechanism in Mammalian Multidrug Resistance Transporters and Their Bacterial Homologs

  2023cites this paper
• Explaining Blood–Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms

  2023cites this paper
• Genetic Predictors of Antipsychotic Efflux Impairment via Blood-Brain Barrier: Role of Transport Proteins

  2023cites this paper
• ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery

  2023cites this paper
• Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review

  2023cites this paper
• Application of therapeutic nanoplatforms as a potential candidate for the treatment of CNS disorders: Challenges and Possibilities.

  2022cites this paper
• The Role of ABC Transporters in Skin Cells Exposed to UV Radiation

  2022cites this paper
• Theoretical and Applied Concepts of Nanocarriers for the Treatment of Parkinson's Diseases

  2022cites this paper
• Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier

  2022cites this paper
• Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms

  2022cites this paper
• and does

  2022cites this paper
• Ether lipid transfer across the blood-brain and placental barriers does not improve by inactivation of the most abundant ABC transporters.

  2022cites this paper
• Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice

  2022cites this paper
• Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems

  2022cites this paper
• A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics

  2022cites this paper
• Organ-specific endothelial cell heterogenicity and its impact on regenerative medicine and biomedical engineering applications.

  2022cites this paper
• Construction and Functional Evaluation of a Three-Dimensional Blood–Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells

  2022cites this paper
• The neurovascular unit in leukodystrophies: towards solving the puzzle

  2022cites this paper
• Transcriptomic Analysis of Rat Cerebral Cortex Reveals the Potential Mechanism of Electroacupuncture Opening Blood Brain Barrier

  2022cites this paper
• Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines

  2022cites this paper
• Modulating the blood–brain tumor barrier for improving drug delivery efficiency and efficacy

  2022cites this paper
• Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis

  2022cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function

  2021cites this paper
• ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy.

  2021cites this paper
• The blood–tumour barrier in cancer biology and therapy

  2021cites this paper
• Electroporation-based Therapy for Brain Tumors: A Review.

  2021cites this paper
• Prevalence of the MDR1 gene mutation in herding dog breeds and Thai Ridgebacks in Thailand

  2021cites this paper
• Kratom Alkaloids: Interactions With Enzymes, Receptors, and Cellular Barriers

  2021cites this paper
• Borneol enhances the protective effect against cerebral ischemia/reperfusion injury by promoting the access of astragaloside IV and the components of Panax notoginseng saponins into the brain.

  2021cites this paper
• Regulation of P-glycoprotein by miR-27a-3p at the brain endothelial barrier.

  2021cites this paper
• Blood–Brain Barrier Dysfunction in the Pathogenesis of Major Depressive Disorder

  2021cites this paper
• Nanostructured Therapeutic Systems of PUFA'S for the Treatment of Glioblastoma Multiforme.

  2020cites this paper
• The potential role of human multidrug resistance protein 1 (MDR1) and multidrug resistance-associated protein 2 (MRP2) in the transport of Huperzine A in vitro

  2020cites this paper
• Polymeric Nanoparticles for the Treatment of Malignant Gliomas

  2020cites this paper
• Restoration of MARCK enhances chemosensitivity in cancer

  2020cites this paper
• Replacing the eleven native tryptophans by directed evolution produces an active P-glycoprotein with site-specific, non-conservative substitutions

  2020cites this paper
• Z-guggulsterone regulates MDR1 expression mainly through the pregnane X receptor-dependent manner in human brain microvessel endothelial cells.

  2020cites this paper
• The constitutive androstane receptor and pregnane X receptor in the brain

  2020cites this paper
• Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance–Associated Protein 2 at the Blood–Brain Barrier

  2020cites this paper
• Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders.

  2020cites this paper
• Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications

  2020cites this paper
• Sera of elderly obstructive sleep apnea patients alter blood–brain barrier integrity in vitro: a pilot study

  2020cites this paper
• The Role of Neurovascular System in Neurodegenerative Diseases

  2020cites this paper
• Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders

  2020cites this paper
• David S. Miller: Scientist, Mentor, Friend—a tribute and thank you

  2020cites this paper
• In Vitro Reversal and Characterization of Multidrug Resistance in Human Cancer Cells

  2020cites this paper
• Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?

  2020cites this paper
• Constitutive Androstane Receptor: A Peripheral and a Neurovascular Stress or Environmental Sensor

  2020cites this paper
• A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity

  2020cites this paper
• Disruption of small molecule transporter systems by Transporter‐Interfering Chemicals (TICs)

  2020cites this paper
• Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

  2020cites this paper
• Neural Progenitor Cell-Derived Extracellular Vesicles Enhance Blood-Brain Barrier Integrity by NF-κB (Nuclear Factor-κB)-Dependent Regulation of ABCB1 (ATP-Binding Cassette Transporter B1) in Stroke Mice

  2020cites this paper
• The brain in flux: Genetic, physiologic, and therapeutic perspectives on transporters in the CNS.

  2019cites this paper
• P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice

  2019cites this paper
• A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine

  2019cites this paper
• Imaging P-Glycoprotein Induction at the Blood–Brain Barrier of a β-Amyloidosis Mouse Model with 11C-Metoclopramide PET

  2019cites this paper
• Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport

  2019cites this paper
• Perivascular and Perineural Pathways Involved in Brain Delivery and Distribution of Drugs after Intranasal Administration

  2019cites this paper
• Hypoxic-ischemic related cerebrovascular changes and potential therapeutic strategies in the neonatal brain

  2019cites this paper
• Nanoparticle-mediated drug delivery: blood-brain barrier as the main obstacle to treat infectious diseases in CNS.

  2019cites this paper
• Intranasal Methylprednisolone Effectively Reduces Neuroinflammation in Mice With Experimental Autoimmune Encephalitis.

  2019cites this paper
• Nanoformulations for glioblastoma multiforme: a new hope for treatment.

  2019cites this paper
• Challenging the CNS Targeting Potential of Systemically Administered Nanoemulsion Delivery Systems: a Case Study with Rapamycin-Containing Fish Oil Nanoemulsions in Mice

  2019cites this paper
• Brain metastases in oncogene-driven non-small cell lung cancer.

  2019cites this paper
• Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors

  2019cites this paper
• Potential Regulation Mechanism of P-gp in the Blood-Brain Barrier in Hypoxia.

  2019cites this paper
• Cellular and molecular mechanisms of glioblastoma malignancy: Implications in resistance and therapeutic strategies.

  2019cites this paper
• ABC transporters in neurological disorders: an important gateway for botanical compounds mediated neuro-therapeutics.

  2019cites this paper
• Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction

  2018cites this paper
• Altered Function and Expression of ABC Transporters at the Blood–Brain Barrier and Increased Brain Distribution of Phenobarbital in Acute Liver Failure Mice

  2018cites this paper
• Efflux proteins at the blood–brain barrier: review and bioinformatics analysis

  2018cites this paper
• Natural Acylated Anthocyanins and Other Related Flavonoids: Structure Elucidation of Ipomoea cairica Compounds and QSAR Studies Including Multidrug Resistance

  2018cites this paper
• Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury

  2018cites this paper
• P-glycoprotein and chronic rhinosinusitis

  2018cites this paper
• Targeted Theranostic Nanoparticles for Brain Tumor Treatment

  2018cites this paper
• Mechanism of drug extrusion by brain endothelial cells via lysosomal drug trapping and disposal by neutrophils

  2018cites this paper
• In Vitro Modulation of Redox and Metabolism Interplay at the Brain Vascular Endothelium: Genomic and Proteomic Profiles of Sulforaphane Activity

  2018cites this paper
• Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences

  2018cites this paper
• Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats

  2018influential citation
• Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

  2018cites this paper